ATC Group: A07EC02 Mesalazine

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Alimentary tract and metabolism
2
Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3
Intestinal antiinflammatory agents
4
Aminosalicylic acid and similar agents
5
A07EC02
Mesalazine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
1.5 g
RECTAL - Rectal
1.5 g

Active ingredients

Active Ingredient
Description

Mesalazine is an aminosalicylate. The mechanism of action of mesalazine is not fully understood, but appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with chronic inflammatory bowel disease, and it is possible that mesalazine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon.

Medicines in this ATC group

Drug
Countries

Australia Canada Cyprus Estonia Finland ...

Brazil

Italy New Zealand Poland

Austria

Tunisia

Austria Germany Italy Spain

South Africa

France

Ireland

Cyprus Ecuador

Brazil Lithuania

Australia South Africa

Tunisia

Ecuador

Australia Austria Canada Cyprus Estonia ...

Canada

United Kingdom

Australia Austria Brazil Canada Cyprus ...

France Tunisia United States

Poland

Australia Austria Canada Cyprus Ecuador ...

Austria Estonia Lithuania Netherlands

United Kingdom

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
MT
Summary of Product Characteristics (SPC)
MT
Summary of Product Characteristics (SPC)
AU
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Structured Product Labeling (SPL)
US